Стоит всегда помнить: обижать людей нехорошо. Они еще могут вам пригодиться. Шутить над кем-то лично может быть обидно и за это надо держать ответ. Считать несерьезным что-то безличное, или шутить над этим, или относиться цинично – нормально, ограничивать эту нормальность под предлогом защиты чьи-то эфемерных чувств – бред, который сам себя убьет, делая защищаемых только слабее.
The Cachrane Hostility https://cachrane.org
The Hawthorne Effect: a randomised, controlled trial. McCarney R, Warner J et al. BMC medical research methodology, 2007. PMC1936999
Spontaneous improvement in randomised clinical trials: meta-analysis. Lasse Theis Krogsbøll, Asbjørn Hróbjartsson and Peter C Gøtzsche. BMC medical research methodology, 2009. PMC2628943
Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. Н. С. Андреева, О. Ю. Реброва, Н. А. Зорин. Медицинские технологии, 2012. http://own.0x3.ru/index.php/s/rMyEPGbjqIDBtoG
Христиан Георг Шморль. http://neuro-online.ru/novosti/hristian-georg-shmorl-nem-christian-georg-schmorl-nemeckii-vrach-i-patolog.html
Antenatal factors in the development of the lumbar vertebral canal. Jeffrey JE, Campbell DM et al. Spine, 2003. PMID:12838100
Prof. Karel Lewit. http://www.ckp-dobrichovice.cz/prof-lewit/zivotopis/
Образовательная программа по мануальной терапии. http://own.0x3.ru/index.php/s/QE3b5qWYY1f2BGB
Барвинченко А. А. «Атлас мануальной медицины». http://own.0x3.ru/index.php/s/MXGLjjqQqcTipiH
Журнал «Мануальная терапия». http://own.0x3.ru/index.php/s/wkW596tGdNYW8Wy
Spinal manipulative therapy for acute low-back pain. Rubinstein SM, Terwee CB et al. Cochrane Back and Neck Group, 2012. DOI:10.1002/14651858.CD008880.pub2
Spinal manipulative therapy for chronic low-back pain. Rubinstein SM, van Middelkoop M et al. Cochrane Back and Neck Group, 2011. DOI:10.1002/14651858.CD008112.pub2
Assessment of diclofenac or spinal manipulative therapy, or both. Hancock JM, Maher GC et al. The Lancet, 2007. http://own.0x3.ru/index.php/s/6uAfxpucbrpSgfE
A systematic review of systematic reviews of spinal manipulation. E Ernst, P H Canter. Journal of the royal society of medicine, 2006. DOI:10.1258/jrsm.99.4.192
Manual therapy for asthma. Maria A Hondras, Klaus Linde, Arthur P Jones. Cochrane Airways Group, 2005. DOI:10.1002/14651858.CD001002.pub2
Manual therapy for osteoarthritis of the hip or knee – a systematic review. H. P. French, A. Brennan et al. Manual therapy, 2011. DOI:10.1016/j.math.2010.10.011.
Sources of bias in reviews of spinal manipulation for back pain. Canter PH, Ernst E. Wiener klinische Wochenschrift – Springer, 2005. PMID:15989112
Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease. Blacker D, Albert MS et al. Archives of neurology, 1994. PMID:7986174
Survival and cause of death in Alzheimer’s disease and multi-infarct dementia. Mölsä PK, Marttila RJ, Rinne UK. Acta neurologica Scandinavica, 1986. PMID:3776457
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease. Shmidt R, Hofer E et al. European journal of neurology, 2015. DOI:10.1111/ene.12707
Bilingualism as a protection against the onset of symptoms of dementia. Bialystok E, Craik IMF, Freedman M. Neuropsychologia, 2007. DOI:10.1016/j.neuropsychologia.2006.10.009
Can Alzheimer’s disease be prevented? http://own.0x3.ru/index.php/s/BBF64M03L50gNbi
Dietary factors and Alzheimer’s disease. Luchsinger JA, Mayeux R. The Lancet neurology, 2004. PMID:15380154
Diet and Alzheimer’s disease. Luchsinger JA1, Noble JM, Scarmeas N. Current neurology and neuroscience reports, 2007.PMID:17764625
Medications and diet: protective factors for AD? Claudia H. Kawas, Alzheimer disease & associated disorders, 2012. PMC3373253
Decline in Weight and Incident Mild Cognitive Impairment. Alhurani ER, Vassilaki M et al. JAMA neurology, 2016. DOI:10.1001/jamaneurol.2015.4756.
Магазаник Н. А., «Диагностика без анализов».
Ultrasound screening in pregnancy: a systematic review. Bricker L, Garcia J et al. Health Technology Assessment, 2000. PMID:11070816
Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Whisnant JP. Neurology, 1996. PMID:8614485
Smoking and risk of stroke. Hankey GJ. Journal of cardiovascular risk, 1999. PMID:10501270
Smoking cessation and the risk of stroke in middle-aged men. Wannamethee SG, Shaper AG et al. JAMA, 1995. PMID:7596004
Obesity. Haslam WD, James TP. The Lancet, 2005. DOI:10.1016/S0140–6736(05)67483–1
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment. The Lancet, 1998. PMID:9742976
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study. Dormandy AJ, Charbonnel B et al. The Lancet, 2005. DOI:10.1016/S0140–6736(05)67528–9
Thrombolysis for acute ischaemic stroke. Wardlaw MJ, Murray V et al. Cochrane Stroke Group, 2014. PMC4153726
Global and regional burden of stroke during 1990–2010. Feigin LV, Forouzanfar HM et al. The Lancet, 2014. PMC4181600
Life After a Stroke. http://www.nhlbi.nih.gov/health/health-topics/topics/stroke/lifeafter
Stroke. Donnan AG, Fisher M et al. The Lancet, 2008. DOI:10.1016/S0140–6736(08)60694–7
Definition and evaluation of transient ischemic attack – AHA/ASA Scientific Statement. Stroke, 2009. DOI:10.1161/STROKEAHA.108.192218
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial. Berge EP, Cohen G et al. The Lancet Neurology, 2016. DOI:10.1016/S1474–4422(16)30139–9
Meditation therapy for anxiety disorders. Krisanaprakornkit T, Sriraj W et al. Cochrane Common Mental Disorders Group, 2006. DOI:10.1002/14651858.CD004998.pub2
Д.А.Леонтьев «Экзистенциальная тревога и как с ней не бороться». Московский Психотерапевтический Журнал 2003, № 2
Tips to Manage Anxiety and Stress. https://www.adaa.org/tips-manage-anxiety-and-stress
Treatment of the depressive phase of bipolar affective disorder: a review. Muneer A. JPMA, 2013. PMID:23901682
Genetics of bipolar disorder. Berit Kerner. Journal of The Application of Clinical Genetics, 2014. PMC3966627
Characteristics and duration of mania: implications for continuation treatment. Steve Titmarsh. Progress in Neurology and Psychiatry, 2013. DOI:10.1002/pnp.283
Bipolar disorder and substance abuse. Robert M. Post and Peter Kalivas. The British Journal of Psychiatry, 2013. PMC4340700
Mood episodes and mood disorders. Beesdo K, Hofler M et al. Bipolar Disorders, 2009. DOI:10.1111/j.1399–5618.2009.00738.x
Psychosocial disability in the course of bipolar I and II disorders. Judd LL, Akiskal SH et al. JAMA psychiatry, 2005. DOI:10.1001/archpsyc.62.12.1322
Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Swann CA, Lafer B et al. The American journal of psychiatry, 2013. DOI:10.1176/appi.ajp.2012.12030301
Читать дальше
Конец ознакомительного отрывка
Купить книгу